Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27035413)

  • 1. Effect of Recepteur d'Origine Nantais expression on chemosensitivity and tumor cell behavior in colorectal cancer.
    Kim N; Cho SB; Park YL; Park SY; Myung E; Kim SH; Yu HM; Son YA; Myung DS; Lee WS; Joo YE
    Oncol Rep; 2016 Jun; 35(6):3331-40. PubMed ID: 27035413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RON is associated with tumor progression via the inhibition of apoptosis and cell cycle arrest in human gastric cancer.
    Song YA; Park YL; Kim KY; Myung E; Chung CY; Cho SB; Lee WS; Jung YD; Kweon SS; Joo YE
    Pathol Int; 2012 Feb; 62(2):127-36. PubMed ID: 22243783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of KITENIN on tumor angiogenesis and lymphangiogenesis in colorectal cancer.
    Oh HH; Park KJ; Kim N; Park SY; Park YL; Oak CY; Myung DS; Cho SB; Lee WS; Kim KK; Joo YE
    Oncol Rep; 2016 Jan; 35(1):253-60. PubMed ID: 26496979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of RON in colorectal cancer and its relationships with tumor cell behavior and prognosis.
    Park YL; Lee GH; Kim KY; Myung E; Kim JS; Myung DS; Park KJ; Cho SB; Lee WS; Jung YD; Kim HS; Joo YE
    Tumori; 2012; 98(5):652-62. PubMed ID: 23235762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the receptor tyrosine kinase recepteur d'origine nantais and its association with tumor progression in hypopharyngeal cancer.
    Yoon TM; Kim SA; Park YL; Lee KH; Sung MW; Lee JK; Lim SC; Chung IJ; Joo YE
    Head Neck; 2013 Aug; 35(8):1106-13. PubMed ID: 22887469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of RON inhibits AP-1 activity and induces apoptosis and cell cycle arrest through the modulation of Akt/FoxO signaling in human colorectal cancer cells.
    Chung CY; Park YL; Song YA; Myung E; Kim KY; Lee GH; Ki HS; Park KJ; Cho SB; Lee WS; Jung YD; Kim KK; Joo YE
    Dig Dis Sci; 2012 Feb; 57(2):371-80. PubMed ID: 21901254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small interfering RNA-directed targeting of RON alters invasive and oncogenic phenotypes of human hepatocellular carcinoma cells.
    Cho SB; Park YL; Song YA; Kim KY; Lee GH; Cho DH; Myung DS; Park KJ; Lee WS; Chung IJ; Choi SK; Kim KK; Joo YE
    Oncol Rep; 2011 Dec; 26(6):1581-6. PubMed ID: 21874262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small interfering RNA targeting of Recepteur d'Origine Nantais induces apoptosis via modulation of nuclear factor-kappaB and Bcl-2 family in gastric cancer cells.
    Park JS; Park JH; Lee S; Joo YE; Jung YD
    Oncol Rep; 2010 Sep; 24(3):709-14. PubMed ID: 20664977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RON (recepteur d'origine nantais) expression and its association with tumor progression in laryngeal squamous cell carcinoma.
    Kim SA; Yoon TM; Lee DH; Park YL; Lee KH; Lim SC; Joo YE; Lee JK
    Auris Nasus Larynx; 2014 Apr; 41(2):201-6. PubMed ID: 24287326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor tyrosine kinase, RON, promotes tumor progression by regulating EMT and the MAPK signaling pathway in human oral squamous cell carcinoma.
    Kim SA; Lee KH; Lee DH; Lee JK; Lim SC; Joo YE; Chung IJ; Noh MG; Yoon TM
    Int J Oncol; 2019 Aug; 55(2):513-526. PubMed ID: 31268163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Filamin A interacting protein 1-like expression inhibits progression in colorectal cancer.
    Park YL; Park SY; Lee SH; Kim RB; Kim JK; Rew SY; Myung DS; Cho SB; Lee WS; Kim HS; Joo YE
    Oncotarget; 2016 Nov; 7(44):72229-72241. PubMed ID: 27750216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospero homeobox 1 mediates the progression of gastric cancer by inducing tumor cell proliferation and lymphangiogenesis.
    Park KJ; Cho SB; Park YL; Kim N; Park SY; Myung DS; Lee WS; Kweon SS; Joo YE
    Gastric Cancer; 2017 Jan; 20(1):104-115. PubMed ID: 26759228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1alpha-mediated invasion of breast carcinoma cells.
    Thangasamy A; Rogge J; Ammanamanchi S
    J Biol Chem; 2009 May; 284(21):14001-10. PubMed ID: 19307182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-mediated gene silencing of the RON receptor tyrosine kinase alters oncogenic phenotypes of human colorectal carcinoma cells.
    Xu XM; Wang D; Shen Q; Chen YQ; Wang MH
    Oncogene; 2004 Nov; 23(52):8464-74. PubMed ID: 15378025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-375 Functions as a Tumor-Suppressor Gene in Gastric Cancer by Targeting Recepteur d'Origine Nantais.
    Lian S; Park JS; Xia Y; Nguyen TT; Joo YE; Kim KK; Kim HK; Jung YD
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27689991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chrysin inhibits cell invasion by inhibition of Recepteur d'origine Nantais via suppressing early growth response-1 and NF-κB transcription factor activities in gastric cancer cells.
    Xia Y; Lian S; Khoi PN; Yoon HJ; Han JY; Chay KO; Kim KK; Jung YD
    Int J Oncol; 2015 Apr; 46(4):1835-43. PubMed ID: 25625479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel recepteur d'origine nantais/c-met small-molecule kinase inhibitor with antitumor activity in vivo.
    Zhang Y; Kaplan-Lefko PJ; Rex K; Yang Y; Moriguchi J; Osgood T; Mattson B; Coxon A; Reese M; Kim TS; Lin J; Chen A; Burgess TL; Dussault I
    Cancer Res; 2008 Aug; 68(16):6680-7. PubMed ID: 18701492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological significance of abnormal recepteur d'origine nantais and programmed death ligand 1 expression in colorectal cancer.
    Liu YZ; Han DT; Shi DR; Hong B; Qian Y; Wu ZG; Yao SH; Tang TM; Wang MH; Xu XM; Yao HP
    World J Gastrointest Oncol; 2020 Nov; 12(11):1216-1236. PubMed ID: 33250957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder.
    Cheng HL; Liu HS; Lin YJ; Chen HH; Hsu PY; Chang TY; Ho CL; Tzai TS; Chow NH
    Br J Cancer; 2005 May; 92(10):1906-14. PubMed ID: 15870710
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.